<DOC>
	<DOC>NCT02063360</DOC>
	<brief_summary>The purpose of this study is to determine if there is an interaction in healthy subjects taking BMS-663068 with Darunavir/Ritonavir and/or Etravirine.</brief_summary>
	<brief_title>DDI Study of BMS-663068 With Etravirine (ETR) and/or Darunavir (DVR) + Ritonavir (RTV)</brief_title>
	<detailed_description>Brief title: drug-drug interaction (DDI) Primary Purpose: Other : Phase 1 Clinical Pharmacology drug interaction study in healthy subjects</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Darunavir</mesh_term>
	<mesh_term>Etravirine</mesh_term>
	<criteria>Healthy subjects with no clinically significant deviation from normal in medical history, physical examination findings, 12lead ECG measurements, and clinical laboratory tests Women of childbearing potential (WOCBP) allowed. Must be practicing highly effective methods of contraception Any significant acute or chronic medical condition Unable to tolerate oral medications Inability to be venipunctured and/or tolerate venous access Current or recent (within 3 months of dosing) gastrointestinal disease Abnormal liver function test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>